genetic testing Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium The OlympiA trial showed a disease-free survival benefit with adjuvant PARP inhibitor therapy for early-stage, BRCA1/2-mutated, HER2-negative breast cancer patients. EHR-Based Model Predicts Patients Who May Benefit from Genetic Testing for Rare Disease Researchers from Vanderbilt University Medical Center said their approach could systematize who undergoes testing and shorten diagnostic odysseys. Fulgent Genetics Makes $19M Investment in Chinese JV, Takes Controlling Interest Fulgent formed the joint venture in 2017 in order to establish a presence in China for its sequencing-based genetic testing services. InformedDNA Partners With Gene Therapy Firm Passage Bio on Dementia Genetic Testing InformedDNA will provide genetic testing to patients diagnosed with frontotemporal dementia to see if they are eligible for certain clinical studies. Pathogenic Germline Structural Variants May Be Missed by Some Testing Approaches Researchers at Color Health reported that intronic data is needed to uncover pathogenic structural variants linked to hereditary cancers or cardiovascular disorders. Apr 14, 2021 Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy Apr 12, 2021 HudsonAlpha Health Alliance, Auburn University Form Genetic Testing Partnership Apr 7, 2021 Preconception Genetic Testing Firm Orchid Raises $4.5M in Seed Funding Mar 31, 2021 GeneMatters, Concert Genetics Form Clinical Genetics Services Alliance Mar 10, 2021 Agena Inks MassArray Distribution Deal for Middle East, Africa, Central Asia Feb 10, 2021 Tataa Biocenter Takes Majority Stake in Swedish Genetic Testing Firm Life Genomics Jan 25, 2021 Sano Genetics Raises £2.5M in Private Seed Funding Jan 4, 2021 Color Raises $167M in Series D Financing Round Dec 7, 2020 Solvd Health Gets CE Mark for Opioid Use Disorder Risk Assessment Test Nov 17, 2020 Impact Lab Group to Acquire HeartGenetics Nov 10, 2020 Genosity, Igentify Collaborate on Genetic Counseling Software, Ink Comarketing Deal Nov 9, 2020 Invitae, Passage Bio Collaborate on GM1 Genetic Testing, Clinical Trial Education Nov 5, 2020 Jackson Laboratory Wins $3.4M NHGRI Grant to Study Workplace Genomic Testing Oct 21, 2020 Sanofi Commits $1M to Support Parkinson's Disease Genetic Testing Study Oct 7, 2020 Patia Biopharma, Precision Diabetes to Collaborate on Diabetes Biomarker Development Aug 19, 2020 Oppenheimer Initiates Coverage of Fulgent Genetics With Outperform Rating Aug 4, 2020 Fulgent Genetics Revenues More Than Double in Q2, Driven by COVID-19 Testing Jul 29, 2020 Sema4 Raises $121M in Series C Financing Round Jun 1, 2020 ACMG Offers Guidance on Incorporating Genomic Data into Electronic Health Records May 29, 2020 BTIG Initiates Coverage of Fulgent Genetics Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.